Trials and Noteworthy Treatments

			Treatment		Location		Last Updated
	Details		A Phase I Trial and Pharmacokinetic Study of Trabectedin (Yondelis®, ET-743) in Children and Adolescents With Relapsed or Refractory Solid Tumors		Bethesda, MD		04/22/2009
	Details		A Phase I/II Trial of ZD6474 for Patients With Recurrent High-Grade and Progressive Low-Grade Gliomas		Bethesda, MD		04/22/2009
	Details		Multiple Ascending Dose (MAD) Study of the IGF-1R Antagonist R1507 Administered as an Intravenous Infusion in Pediatric Patients With Advanced Solid Tumors.		Bethesda, MD		04/22/2009
	Details		Phase II Trial of Bevacizumab (Avastin)for Patients With Recurrent High-Grade Glioma		Bethesda, MD		04/21/2009
	Details		Phase I Trial of Conditionally Replication-Competent Adenovirus (Delta-24-RGD4C) for recurrent malignant glioma		Houston, TX		04/14/2009
	Details		A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas		San Francisco, CA		04/06/2009
	Details		Quality of Life in Patients with Brain Tumors, Skull Base Tumors & Pituitary Adenomas Undergoing Surgical Resection		Santa Monica, CA		11/29/2008
	Details		Bevacizumab (Avastin) and Irinotecan (CPT-11) in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma		San Francisco, CA Washington, DC Chicago, IL Boston, MA Bethesda, MD Durham, NC Philadelphia, PA Pittsburgh, PA Memphis, TN Seattle, WA		11/08/2008
	Details		A Phase II Trial of Thalidomide in combination with Temozolomide or CPT-11 in patients with recurrent anaplastic gliomas or glioblastoma multiforme		Houston, TX		10/27/2008
	Details		Phase I Trial of Aflibercept (VEGF Trap)with Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Malignant Gliomas		Los Angeles, CA San Francisco, CA Boston, MA Durham, NC New York, NY Pittsburgh, PA Houston, TX San Antonio, TX Madison, WI		10/27/2008
	Details		BIBW 2992 with or without daily temozolomide in the treatment of patients with recurrent malignant glioma		Charlottesville, VA		10/20/2008
	Details		Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma		Charlottesville, VA		09/30/2008
	Details		Gliogene: An International Brain Tumor Study		Houston, TX		07/24/2008
	Details		Phase I/II Trial of Irinotecan plus Lenalidomide in Adult Patients with Recurrent Glioblastoma Multiforme		Houston, TX		05/28/2008
	Details		Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients with Malignant Glioma		Houston, TX		05/28/2008
	Details		Phase I / II Adaptive Randomized Trial of Vorinostat, Isotretinoin and Carboplatin in Adults with Recurrent Glioblastoma Multiforme		Houston, TX		04/15/2008
	Details		Phase I/II Study of OSI-774 (Erlotinib) and CCI-779 (Temsirolimus) in Patients with Recurrent Malignant Glioma		Houston, TX		04/15/2008
	Details		A Phase I Study of Vorinostat [Suberoylanilide Hydroxamic Acid (SAHA)] in Combination with Temozolomide in Patients with Malignant Gliomas		Los Angeles, CA Boston, MA Durham, NC New York, NY Houston, TX		04/15/2008
	Details		Combination of 6-Thioguanine, Capecitabine, Celecoxib and Temozolomide or CCNU for Recurrent Anaplastic Glioma		Houston, TX		04/15/2008
	Details		Phase I Dose Escalation Study of Autologous Tumor Lysate-Pulsed Dendritic Cell Immunotherapy for Malignant Gliomas in Pediatric Patients		Los Angeles, CA		03/02/2008
	Details		Phase I Study of Glioma-Associated Antigen (GAA) Peptide-Pulsed Dendritic Cell Vaccination in Malignant Glioma Patients		Los Angeles, CA		03/02/2008
	Details		Phase I Study of Immunization With Autologous Tumor Lysate-Pulsed Dendritic Cells in Patients With Malignant Gliomas (Vaccine Therapy in Treating Patients With Malignant Glioma)		Los Angeles, CA		03/02/2008
	Details		Phase I/II Study of GP96 Heat Shock Protein-Peptide Complex Vaccine in Patients With Recurrent or Progressive High-Grade Glioma		San Francisco, CA		03/02/2008
	Details		Phase ll Trial of Tumor Lysate-Pulsed Dendritic Cell Immunotherapy for Patients With Atypical or Malignant, Primary or Metastatic Brain Tumors of the Central Nervous System		Los Angeles, CA		03/02/2008
	Details		A phase I/II Evaluation of Vaccination with Type-1 Dendritic Cells Pulsed With Multiple Peptides In the Treatment of HLA-A2 Positive Patients With Recurrent Malignant Gliomas		Pittsburgh, PA		03/02/2008
	Details		NTI 0501: An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) (Xerecept) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302 or NTI 0303		Kingston, Ontario, CANADA Edmonton, Alberta, CANADA Moncton, New Brunswick, CANADA Ottawa, Ontario, CANADA Toronto, Ontario, CANADA Winnipeg, Manitoba, CANADA Phoenix, AZ La Jolla, CA Palo Alto, CA Sacramento, CA Aurora, CO Englewood, CO Jacksonville, FL Orlando, FL Chicago, IL Evanston, IL Boston, MA Detroit, MI Winston-Salem, NC Edison, NJ Buffalo, NY Columbus, OH Columbus, OH Portland, OR Memphis, TN Nashville, TN Seattle, WA Madison, WI		03/01/2008
	Details		Phase II Study Of 7 Days On/7 Days Off Temozolomide In Patients With High-Grade Glioma		San Francisco, CA		01/17/2008
	Details		NABTC 04-03: A Phase I Study of Vorinostat (Suberolyanilide Hydroxamic Acid [SAHA]) in Combination with Temozolomide in Patients with Malignant Gliomas		San Francisco, CA		10/03/2007
	Details		NABTC 04-02: Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma		Los Angeles, CA Boston, MA Durham, NC New York, NY Pittsburgh, PA Houston, TX San Antonio, TX Madison, WI		10/03/2007
	Details		A Phase 1/11 Study of Topotecan by Intracerebral Clysis for the Treatment of Recurrent Primary Malignant Brain Tumors		NEW YORK CITY, NY		08/20/2007
	Details		A Phase I Study of Imatinib Mesylate (Gleevec) in Combination With Temozolomide (Temodar) in Patients With Malignant Glioma		Durham, NC		08/20/2007
	Details		A Phase II Safety Study of Bevacizumab in Patients With Multiple Recurrent or Progressive Malignant Gliomas		Chicago, IL		08/20/2007
	Details		Determination of the In-Tumor-Concentration of Imatinib Mesylate (Gleevec) in Malignant Glioma After Oral Administration		Baltimore, MD		08/20/2007
	Details		A Phase II Trial With Bevacizumab (Avastin) and Irinotecan (CPT-11) for Patients With Primary Brain Tumors and Progression After Standard Therapy		Copenhagen, Denmark		08/18/2007
	Details		Combination of 6-Thioguanine, Capecitabine, Celecoxib and Temozolomide or CCNU for Recurrent Anaplastic Glioma and Glioblastoma Multiforme		Houston, TX		08/18/2007
	Details		Identification of Hypermethylated Serum Tumor DNA in High Grade Glioma Patients and Correlation with Magnetic Resonance Imaging Findings		Cleveland, OH		08/18/2007
	Details		Phase I study of Gefitinib plus Rapamycin for patients with recurrent malignant glioma.		Los Angeles, CA Durham, NC		08/18/2007
	Details		A Phase II Trial to Evaluate the Effect of Low Dose Temozolomide (TMZ) for 2 Weeks (Pre-Surgery) on Brain Tumor O-6-Methylguanine-DNA Methyltransferase (MGMT) Activity in Patients With Gliomas.		Montreal, Canada		08/18/2007
	Details		Brain Mapping for Brain Tumors		Boston, MA		08/18/2007
	Details		Functional image guided removal of brain tumors		Manhasset, NY		08/18/2007
	Details		A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Glioma		Los Angeles, CA		08/04/2007
	Details		Evaluation of a Stress Reduction Program in Patients With Malignant Brain Tumors and Their Family Caregivers		Cleveland, OH		05/01/2007
	Details		Phase I and II, Open-Label, Multi-Center Trials of Pazopanib in Combination With Lapatinib in Adult Patients With Relapsed Malignant Glioma		Tampa, FL Atlanta, GA Chicago, IL Boston, MA Detroit, MI Durham, NC Cleveland, OH		05/01/2007
	Details		Phase I Evaluation of Sodium Stibogluconate in Combination With Interferon a-2b for Solid Tumors, Lymphoma or Myeloma		Cleveland, OH		05/01/2007
	Details		Phase I/II Study of Intravenous Infusion of Tetra-o-Methyl Nordihydroguaiaretic Acid (EM-1421) in Subjects With Recurrent High Grade Glioma		Birmingham, AL Tampa, FL Atlanta, GA Boston, MA Baltimore, MD Detroit, MI Winston-Salem, NC Cleveland, OH Philadelphia, PA		05/01/2007
	Details		Phase II Trial of Continuous Dose Temozolomide in Patients With Newly Diagnosed Pure and Mixed Anaplastic Oligodendroglioma		Cleveland, OH		05/01/2007
	Details		Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma		Detroit, MI		05/01/2007
	Details		Phase II Randomized Study of Intra-Arterial Carboplatin, Cyclophosphamide, and Etoposide or Etoposide Phosphate With or Without Delayed High-Dose Sodium Thiosulfate in Patients With High-Grade Glioma		Cleveland, OH Columbus, OH Portland, OR		05/01/2007
	Details		Phase III Randomized Study of Radiotherapy Combined With Temozolomide Versus Carmustine in Patients With Anaplastic Astrocytoma or Mixed Gliomas		Jacksonville, FL Boston, MA Rochester, MN Cleveland, OH		05/01/2007
	Details		RTA 744 in Treating Patients With Recurrent or Refractory Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Anaplastic Mixed Oligoastrocytoma, Glioblastoma Multiforme, or Gliosarcoma		Los Angeles, CA Dallas, TX		11/21/2006
	Details		Phase I/II Trial of Oral Erlotinib (Tarceva, OSI-774) for Treatment of Relapsed/Refractory Glioblastoma Multiforme and Anaplastic Astrocytoma		New York, NY		10/12/2006
	Details		Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study)		, , Canada , Canada , Canada , Canada , Canada , Canada , Switzerland , Switzerland Auckland, New Zealand Perth, Western Australia, 6001, Australia Randwick, New South Wales, 2031, Australia Phoenix, AZ Downey, CA Loma Linda, CA Los Angeles, CA Los Angeles, CA Los Angeles, CA Madera, CA Oakland, CA Orange, CA Orange, CA Sacramento, CA San Francisco, CA Santa Barbara , CA Travis Air Force Base, CA Denver, CO Farmington, CT Washington, DC Washington, DC Wilmington, DE Atlanta, GA Macon, GA Savannah, GA Des Moines, IA Chicago, IL Chicago, IL Park Ridge, IL Indianapolis, IN Springfield, MA Baltimore, MD Ann Arbor, MI Detroit, MI Grand Rapids, MI Kalamazoo, MI Royal Oak, MI Royal Oak, MI Minneapolis, MN Rochester, MN Kansas City, MO Chapel Hill, NC Charlotte, NC Winston-Salem, NC Fargo, ND Omaha, NE Omaha, NE Brunswick, NJ Newark, NJ Paterson, NJ Summit, NJ Las Vegas, NV Albany, NY Bronx, NY Brooklyn, NY Brooklyn, NY Brooklyn, NY Brooklyn, NY New Hyde Park, NY New York, NY Stony Brook, NY Syracuse, NY Akron, OH Cincinnati, OH Cleveland, OH Columbus, OH Dayton, OH Toledo, OH Portland, OR Danville, PA Philadelphia, PA Pittsburgh, PA Sioux Falls, SD Johnson City, TN Knoxville, TN Nashville, TN Amarillo, TX Austin, TX Dallas, TX Houston, TX Lubbock, TX San Antonio, TX San Antonio, TX Temple, TX Norfolk, VA Seattle, WA Seattle, WA Spokane, WA Tacoma, WA Green Bay, WI Green Bay, WI Green Bay, WI La Crosse, WI Madison, WI Marshfield, WI Marshfield, WI Huntington, WV		10/12/2006
	Details		Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma		Jacksonville, FL Jacksonville, FL Des Moines, IA Moline, IL Peoria, IL Urbana, IL Wichita, KS Lambertville, MI Rochester, MN Saint Louis Park, MN Billings, MT Bismarck, ND Lincoln, NE Danville, PA Spartanburg, SC Sioux Falls, SD		06/26/2006
	Details		Pilot Randomized Study of Modafinil for Treatment of Fatigue and Neurobehavioral Dysfunction in Patients With Primary Brain Tumors		Los Angeles, CA		05/29/2006
	Details		Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors		Washington, DC Chicago, IL Boston, MA Bethesda, MD Philadelphia, PA Pittsburgh, PA Memphis, TN Houston, TX Seattle, WA		05/27/2006
	Details		PEG-Interferon alfa-2b With or Without Thalidomide in Treating Patients With Recurrent High-Grade Gliomas		Los Angeles, CA Boston, MA Ann Arbor, MI New York, NY Pittsburgh, PA Houston, TX San Antonio, TX Madison, WI		05/04/2006
	Details		A Phase I Trial Using Combination Irinotecan (CPT-11) and Thalidomide for Recurrent CNS Tumors		Albuquerque, NM		05/02/2006
	Details		A Pilot Study of Dronabinol for the treatment of nausea,vomiting and appetite loss in Adult Patients With Primary Gliomas		Durham, NC		05/01/2006
	Details		Phase II Study of Pemetrexed Disodium (Alimta) in Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain Metastases		Chicago, IL		05/01/2006
	Details		Pilot Study of the Safety and Accuracy of Fluorothymidine F 18 Positron Emission Tomography in Detecting Recurrent Disease in Patients With Gliomas		Seattle, WA		05/01/2006
	Details		Headstart II A Phase II study of two alternative intensive induction chemotherapy followed by consolidation with myeloablative chemotherapy and autologous stem cell rescue with or without subsequent radiation therapy for children less than 10 yrs of age newly diagnosed with malignant brain tumors		Oakland, CA		05/01/2006
	Details		Phase II Study of O6-Benzylguanine and Temozolomide (Temodar) in Pediatric Patients With Recurrent or Progressive High-Grade Gliomas or Brain Stem Tumors		Chicago, IL Bethesda, MD Durham, NC Durham, NC Lincoln, NE Philadelphia, PA Memphis, TN Houston, TX Seattle, WA		05/01/2006
	Details		Phase II trial of Temodar ® plus O6-Benzylguanine in the treatment of patients with Temodar® -resistant malignant glioma.		Durham, NC		12/03/2005
	Details		Pharmacological intervention for learning impaired children surviving treatment for cancer.		Durham, NC		12/03/2005
	Details		Gamma Knife Radiosurgery		Smithtown, NY		12/03/2005
	Details		Gamma Knife Radiosurgery for Brain Tumors		La Jolla, CA		12/03/2005
	Details		Phase I trial of Temodar plus O6-Benzylguanine plus Irinotecan (CPT-11) in the treatment of patients with recurrent/progressive Cerebral anaplastic gliomas.		Durham, NC		12/03/2005
	Details		Phase I trial of Temozolomide (Temodar) and O6-Benzylguanine (o6-bg)in pediatric patients with recurrent brain tumors.		Durham, NC		12/03/2005
	Details		A Phase I dose escalation trial of Temodar that will attempt to determine the maximum tolerated dose of Temodar (Temozolomide) when given by prolonged oral exposure to children with recurrent or progressive brain tumors.		New York, NY		12/03/2005
	Details		Fractionated Stereotactic Radiosurgery plus Topotecan radiation sensitizer in the treatment of recurrent malignant astrocytoma or as consolidation after external beam radiotherapy.		New York, NY		12/03/2005
	Details		Gamma Knife Radiosurgery		Edison, NJ		12/03/2005
	Details		Gamma knife stereotactic radiosurgery for benign and malignant brain tumors and brain metastases.		Rockville Centre, NY		12/03/2005
	Details		Phase I/II Study of Multiple Light Fiber Interstitial Photodynamic Therapy for Primary and Metastatic Supratentorial Brain Tumors		Hershey, PA		12/03/2005
	Details		Quality of Life Studies (There are 19 seperate studies listed here)		Durham, NC		12/03/2005
	Details		Use of Epilepsy Monitoring And Electrocorticography For Seizure Control In Patients With Brain Tumors		Hackensack, NJ		12/03/2005
	Details		A Pilot Study of 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Pediatric Patients with Primary and Metastatic Brain Tumors		Bethesda, MD		11/27/2005
	Details		A Randomized Phase II Study of Peg-Interferon Alpha-2B (Peg-Intron) Alone or in Combination with Thalidomide in Adults with Recurrent High-Grade Gliomas		Los Angeles, CA Boston, MA Ann Arbor, MI New York, NY Pittsburgh, PA Houston, TX San Antonio, TX Madison, WI		11/27/2005
	Details		Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors		Portland, OR		11/27/2005
	Details		Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas		Lanne, Switzerland		11/27/2005
	Details		Computer Assisted Stereotactic Navigation For Resection Of Brain Tumors In Children And Adults		Hackensack, NJ		11/27/2005
	Details		Double sequential high dose Thiotepa with autologous stem cell rescue for patients age <60 years with recurrent malignant brain cancer.		Los Angeles, CA		11/27/2005
	Details		Endoscopic ventriculostomy for obstructive hydrocephalus in terminal patients with hydrocephalus and brain tumours.		Kelantan, Malaysia, MALAYSIA		11/27/2005
	Details		Feasibility of using oral Etoposide combined with escalating doses of Tamoxifen for children with recurrent gliomas		Denver, CO		11/27/2005
	Details		Frameless Computer Guided Stereotactic Surgery For Brain Tumors		New York, NY		11/27/2005
	Details		Functional brain Mapping Of Motor And Speech Areas For Resection Of Tumors Near Functional Areas Of The Brain		Hackensack, NJ		11/27/2005
	Details		Genetic Therapy of meningiomas and gliomas in the Malay population in the NorthnEast coast of Malaysia		Kelantan, Malaysia, MALAYSIA		11/27/2005
	Details		Phase I Dose Escalation Study of Autologous Antigen-Pulsed Dendritic Cell Immunotherapy for Malignant Gliomas (e.g. Glioblastoma Multiforme, Anaplastic Astrocytoma)		Los Angeles, CA Los Angeles, CA		11/27/2005
	Details		Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma		Jacksonville, FL Ames, IA Cedar Rapids, IA Missouri Valley, IA Sioux City, IA Moline, IL Peoria, IL Urbana, IL Wichita, KS Lambertville, MI Duluth, MN Saint Louis Park, MN Billings, MT Bismarck, ND Lincoln, NE Allentown, PA Danville, PA Sayre, PA Spartanburg, SC Rapid City, SD Sioux Falls, SD		11/27/2005
	Details		Pre- and Postoperative Use of ZD1839(Iressa) in Recurrent Glioblastoma, Including Translational Research		Zürich , Switzerland Los Angeles, CA		11/27/2005
	Details		Regulus Navigator for use with a three point pinion - frameless stereotactic surgery		New York, NY		11/27/2005
	Details		Risk Adapted, Multimodal Therapy In Newly Diagnosed Supratentorial Malignant Glioma, Stratified To KPS.		Kreischa Dresden, GERMANY		11/27/2005
	Details		Volumetric Stereotactic Procedures		New York, NY		11/27/2005
	Details		Adoptive IL-2 activated LAK cell intratumoral immunotherapy implant with adjuvant radiosurgery boost and naturopathic/nutritional immune enhancement. This is for newly diagnosed patients only.		Newport Beach, CA		11/26/2005
	Details		Gamma Knife Radiosurgery for Brain Tumors and Arteriovenous and Cavernous Malformations		St.Petersburg, Fl		11/26/2005
	Details		Intra-arterial carboplatin for supratentorial brain tumors		Fort Worth, TX		11/26/2005
	Details		Aggresive emergency tumour debulking and craniectomy for patients with tumours of more than 80ml and glasgow coma scale of less than 8.		Kelantan, Malaysia, MALAYSIA		11/26/2005
	Details		Chemosensitivity assay for malignant brain tumors		Huntington Beach, CA		11/26/2005
	Details		Computer assisted minimally invasive image guided surgery for improved resection of malignant brain tumors and frameless stereotactic brain biopsies For Deep Brain Tumors.		Smithtown, NY		11/26/2005
	Details		Concurrent Temozolomide and Radiotherapy Followed By Dose Dense Versus Metronomic Temozolomide and Maintenance Cis-Retinoic Acid For Patients With Newly Diagnosed Glioblastoma And Other Malignant Gliomas		New York, NY		11/26/2005
	Details		Headstart II A Phase II study of two alternative intensive induction chemotherapy followed by consolidation with myeloablative chemotherapy and autologous stem cell rescue with or without subsequent radiation therapy for children less than 10 yrs of age newly diagnosed with malignant brain tumors		New York, NY		11/26/2005
	Details		Intraoperative navigation in neurosurgical patients		Boston, MA		11/26/2005
	Details		Phase I/II Trial of Temodar and Escalating Doses of Oral VP-16 for Patients with Recurrent Malignant Glioma		Rochester, NY		11/26/2005
	Details		Reliable Imaging Diagnosis of Recurrent Brain Tumor		Winston-Salem, NC		11/26/2005
	Details		Frameless Computer Assisted Stereotactic Surgery for Resection of Brain Tumors in Adults and Children		Rockford, IL		11/25/2005
	Details		Frameless Computer Guided Stereotactic Sugery for Resection of Brain Tumors in Adults and Children		Rockford, IL		11/25/2005
	Details		Brain tumor surgery using a compact intraoperative MRI		Manhasset, NY		11/25/2005
	Details		A trial of Dalteparin low molecular weight heparin for primary prophylaxis of venous thromboembolism in brain tumor patients.		Salt Lake City, UT		11/24/2005
	Details		Use of Hight Dose Tamoxifen For Patients Who Refuse Surgery For meningiomas and Gliomas.		Kelantan, Malaysia, MALAYSIA		11/24/2005
	Details		Oral ST 1481 in adults with Malignant Glioma: a Phase I-II Clinical Trial		Providence, RI		11/21/2005
	Details		Phase I/II trial of Temodar and escalating doses of Oral VP-16 for patients with recurrent malignant gliomas.		Durham, NC		11/20/2005
	Details		Phase II treatment with Irinotecan (CPT-11) plus Celebrex® of adults with primary malignant glioma.		Durham, NC		11/20/2005
	Details		Intraoperative MRI for brain tumors		Boston, MA		11/20/2005
	Details		Activation of A Pilot Comparison Bioavailability Study of Oral and Intravenously Administered Temozolomide (Temodar) in patients with primary CNS malignancies.		Durham, NC		11/13/2005
	Details		Phase I/II trial of ZD1839 (Iressa) in pediatric patients newly diagnosed with brain stem tumors or incompletely resected supratentorial malignant gliomas.		Durham, NC		11/13/2005
	Details		Phase II study of VNP40101M for the treatment of adults with newly diagnosed or recurrent malignant glioma.		Durham, NC		11/13/2005
	Details		Phase I trial of Oral Topotecan plus Temodar in the treatment of patients with recurrent/progressive malignant gliomas.		Durham, NC		11/13/2005
	Details		Pilot study of genetic and environmental Risk and outcome for newly diagnosed brain tumor patients and controls.		Durham, NC		11/13/2005
	Details		Pilot trial of Innohep (Tinzaparin) Low Molecular Weight Heparin for primary prophylaxis of venous thromboembolism in brain tumor patients.		Durham, NC		11/13/2005
	Details		Antineoplaston Therapy in Treating Patients With Brain Tumors		Houston, TX		11/13/2005
	Details		Antineoplaston Therapy in Treating Children With Brain Tumors		Houston, TX		11/11/2005
	Details		Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma		Washington, DC Chicago, IL Baltimore, MD Memphis, TN Dallas, TX Houston, TX		11/11/2005
	Details		Thalidomide and Temozolomide in Treating Young Patients With Relapsed or Progressive Brain Tumors or Recurrent Neuroblastoma		Boston, MA		11/11/2005
	Details		Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Malignant Glioma (Glioblastoma multiforme, Gliosarcoma, Anaplastic astrocytoma, PNET, Oligodendroglioma)		Paterson, NJ New York, NY		11/11/2005
	Details		TP-38 Toxin in Treating Young Patients With Recurrent or Progressive Supratentorial High-Grade Glioma(or Glioblastoma multiforme)		Washington, DC Boston, MA Memphis, TN		11/11/2005
	Details		Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors		, CANADA , Los Angeles, CA Palo Alto, CA Washington, DC Indianapolis, IN Boston, MA Minneapolis, MN Rochester, MN Jackson, MS New York, NY Syracuse, NY Cincinnati, OH Portland, OR Philadelphia, PA Pittsburgh, PA Memphis, TN Dallas, TX Houston, TX Seattle, WA		11/11/2005
	Details		VNP40101M in Treating Young Patients With Recurrent, Progressive, or Refractory Primary Brain Tumors		Washington, DC Chicago, IL Boston, MA Durham, NC Philadelphia, PA Pittsburgh, PA Memphis, TN Houston, TX Seattle, WA		11/11/2005
	Details		A Phase I Gliadel and Escalating Doses of Intravenous O6-Benzylguanine Trial in Patients with Recurrent Malignant Glioma		Baltimore, MD		11/09/2005
	Details		Phase I, Gliadel® & Escalating Doses of Intravenous O6-Benzylguanine in People with Recurrent Malignant Glioma		Winston-Salem, NC		11/09/2005
	Details		Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment		, Puerto Rico Fort Myers, FL Gainesville, FL Jacksonville, FL Pensacola, FL St. Petersburg, FL Tampa, FL West Palm Beach, FL Augusta, GA Indianapolis, IN Grand Rapids, MI Syracuse, NY Akron, OH San Antonio, TX San Antonio, TX Temple, TX Richmond, VA Green Bay, WI		11/06/2005
	Details		Phase I study of Cilengitide in children with refractory brain tumors.		Durham, NC		11/06/2005
	Details		Erlotinib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Glioma		Memphis, TN		11/06/2005
	Details		Radiosurgery with the Varian Trilogy system for benign or malignant brain tumors		Mobile , AL		11/06/2005

News Stories

Sorry - There were no pages found that contain that search phrase.

Frequently Asked Questions

Pages On This Website

(Relevance) Page Title - click title to go to the page!